Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270499 · ClinicalTrials.gov registry record
Aveir VR Real-World Evidence Post-Approval Study
A clinical trial of Bradycardia and Arrythmia, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 2,100
- Enrollment target
- 1
- Study location
NCT05270499 is a study of Bradycardia and Arrythmia that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 2,100 participants, below the 4,340-participant average among 29 other Bradycardia trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05270499, a study of Bradycardia and Arrythmia, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 2,100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this post-approval study is to evaluate the long-term safety of the single-chamber Aveir VR leadless pacemaker using real-world evidence methods.
Conditions Studied
Interventions
- DEVICE Aveir VR Leadless Pacemaker System
Study Locations (1)
California
- Abbott - Sylmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,100 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2034-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05270499
The ClinicalTrials.gov registry entry for NCT05270499 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,340-participant average among 29 other Bradycardia trials with a reported enrollment target (52% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Aveir VR Leadless Pacemaker System is the first listed.
NCT05270499 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05270499 about?
NCT05270499 is a clinical study titled "Aveir VR Real-World Evidence Post-Approval Study". The purpose of this post-approval study is to evaluate the long-term safety of the single-chamber Aveir VR leadless pacemaker using real-world evidence methods.
What is the current status of trial NCT05270499?
This trial is currently recruiting. The enrollment target is 2,100 participants. The study started on 2022-06-21. Estimated completion is 2034-02-28.
What conditions does trial NCT05270499 study?
This clinical trial studies the following conditions: Bradycardia, Arrythmia, Cardiac Pacemaker.
What interventions are being tested in trial NCT05270499?
The interventions under investigation include: Aveir VR Leadless Pacemaker System (DEVICE).
Who is sponsoring clinical trial NCT05270499?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05270499 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
-
Aveir VR Coverage With Evidence Development Post-Approval Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.